SEC Form 4 · accession 0001144204-17-051784
AVENUE THERAPEUTICS, INC. · ATXI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lindsay A Rosenwald M.D.
Director
Period of report
Oct 4, 2017
Accepted (ET)
Oct 10, 2017 · 8:36 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001644963
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 4, 2017 | P | 2,200 | $5.60 | A | 12,200 | D | |
| Common StockF1 | Oct 5, 2017 | P | 3,550 | $5.60 | A | 15,750 | D | |
| Common StockF1 | Oct 6, 2017 | P | 2,900 | $5.63 | A | 18,650 | D | |
| Common StockF1 | Oct 9, 2017 | P | 1,350 | $5.40 | A | 20,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 10,000 shares of restricted stock.